[Adoptive transfer of Epstein-Barr virus-specific T-lymphocytes in chronic active Epstein-Barr infection]

Dtsch Med Wochenschr. 2003 Mar 14;128(11):548-50. doi: 10.1055/s-2003-37849.
[Article in German]

Abstract

History: A 27-year-old man was admitted because of intermittent fever, fatigue, lymphadenopathy and splenomegaly for 20 years. Chronic administration of 6 - 8 g aspirin per day (self-prescribed) resulted in limited control of symptoms and in the development of analgesic nephropathy.

Investigations: The patient had prominent splenomegaly and lymphadenopathy without histological signs of malignancy. Monocytosis and T-lymphopenia were also present. Infectious disease testing revealed IgG+/IgM- EBV serology and EA-EBV-mRNA nested PCR clearly demonstrated the presence of lytic EBV-proteins in PBMCs.

Treatment and course: As chronic active Epstein-Barr virus infection (CAEBV) was highly probable, treatment with aciclovir, gancilovir and steroids was started. Because treatment failed adoptive T-cell transfer with autologous EBV-specific T-cells was performed. After three consecutive infusions the patient responded with a complete remission of fever, fatigue, lymphadenopathy and splenomegaly without adverse effects. Retrospective real-time PCR analysis showed a decrease in viral load from 62847 copies/ microg DNA to 45 - 250 copies after treatment. The patient remains in stable remission without signs of CAEBV (> 4 years).

Conclusion: Adoptive transfer of autologous, EBV-specific T-lymphocytes is a promising treatment in CAEBV.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Acyclovir / therapeutic use
  • Adoptive Transfer*
  • Adult
  • Antibodies, Viral / blood
  • Antigens, Viral / genetics
  • Antiviral Agents / therapeutic use
  • Epstein-Barr Virus Infections / diagnosis
  • Epstein-Barr Virus Infections / therapy*
  • Ganciclovir / therapeutic use
  • Herpesvirus 4, Human / genetics
  • Herpesvirus 4, Human / immunology*
  • Herpesvirus 4, Human / isolation & purification
  • Humans
  • Male
  • Polymerase Chain Reaction
  • RNA, Messenger / analysis
  • Steroids / therapeutic use
  • T-Lymphocytes / immunology*
  • Treatment Failure
  • Viral Load

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • Antiviral Agents
  • Epstein-Barr virus early antigen
  • RNA, Messenger
  • Steroids
  • Ganciclovir
  • Acyclovir